Old Web
English
Sign In
Acemap
>
authorDetail
>
Peter A. Van Der Lubbe
Peter A. Van Der Lubbe
Ludwig Maximilian University of Munich
Rheumatoid arthritis
Medicine
Immunology
Monoclonal antibody
Immunopathology
8
Papers
569
Citations
0.01
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Patient preferences for treatment: report from a randomised comparison of treatment strategies in early rheumatoid arthritis (BeSt trial)
2007
Annals of the Rheumatic Diseases
Y P M Goekoop-Ruiterman
Jeska K. de Vries Bouwstra
Cornelia F. Allaart
Pit J S M Kerstens
B. Grillet
Mike H. de Jager
K. Huub Han
I. Speyer
Peter A. Van Der Lubbe
Patrick E H Seys
Ferdinand C. Breedveld
Ben A. C. Dijkmans
Show All
Source
Cite
Save
Citations (66)
Reduction of synovial inflammation after anti‐cd4 monoclonal antibody treatment in early rheumatoid arthritis
1995
Arthritis & Rheumatism
Paul P. Tak
Peter A. Van Der Lubbe
Alberto Cauli
Mohamed R. Daha
Tom J. M. Smeets
Philip M. Kluin
A. Edo Meinders
Ghada Yanni
G. S. Panayi
Ferdinand C. Breedveld
Show All
Source
Cite
Save
Citations (191)
Treatment of rheumatoid arthritis with a chimeric CD4 monoclonal antibody (cM-T412): immunopharmacological aspects and mechanisms of action.
1994
Scandinavian Journal of Immunology
Peter A. Van Der Lubbe
Christian Reiter
A.M.M. Miltenburg
K. Krüger
A. N. Ruyter
Ernst Peter Rieber
J.A. Bijl
Gert Riethmüller
F. C. Breedveld
Show All
Source
Cite
Save
Citations (23)
Chimeric CD4 monoclonal antibody cM-T412 as a therapeutic approach to rheumatoid arthritis.
1993
Arthritis & Rheumatism
Peter A. Van Der Lubbe
Christian Reiter
Ferdinand C. Breedveld
Klaus Kr¨︁ger
M. Schattenkirchner
Sanders Me
Gert Riethm¨︁ller
Show All
Source
Cite
Save
Citations (78)
1